The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to http://www.galdermausa.com/Our-Commitment/PreBoard-Webinar.aspx.
1. This 45-year-old patient has male pattern hair loss. Which of the following is characteristic of this condition?
a) It occurs in complete androgen insensitivity syndrome.
b) The conversion of dihydrotestosterone to testosterone is catalyzed by type 2 5-α reductase.
c) There are 10 known isoforms of 5-α reductase.
d) This type of hair loss is absent in men with genetic deficiency of type 1 5-α reductase.
e) Inheritance of this type of hair loss is mostly polygenic.
2. This young woman has her nails done professionally every week. She recently developed multiple areas of nontender swelling that involve the proximal and lateral nail fold. Which one of the following systemic agents is likely to help this condition?
e) Interferon alpha